This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
₹4,456
Share price
0.00%
Change (1 day)
37.58%
Change (1 year)
Categories
Earnings for ChemoCentryx (CCXI)
Earnings in 2022 (TTM): -₹9.92 Billion
According to ChemoCentryx's latest financial reports the company's current earnings are ₹37.2 Million. In 2021 the company made an earning of -₹11.07 Billion a decrease over its 2020 earnings that were of -₹4.52 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for ChemoCentryx from 2011 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -₹9.92 Billion | -10.4% |
| 2021 | -₹11.07 Billion | 144.84% |
| 2020 | -₹4.52 Billion | -1.18% |
| 2019 | -₹4.58 Billion | 45.17% |
| 2018 | -₹3.15 Billion | -305.69% |
| 2017 | ₹1.53 B | -144.7% |
| 2016 | -₹3.43 Billion | -15.52% |
| 2015 | -₹4.06 Billion | 0.85% |
| 2014 | -₹4.02 Billion | 21.47% |
| 2013 | -₹3.31 Billion | -1.24% |
| 2012 | -₹3.36 Billion | 906.88% |
| 2011 | -₹0.34 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | ₹163.34 B | -1,559.42% | 🇺🇸 USA |
 | ₹318.46 B | -2,945.33% | 🇺🇸 USA |
 | ₹376.61 B | -3,464.89% | 🇬🇧 UK |
 | -₹718.09 Billion | 6,315.77% | 🇺🇸 USA |
 | ₹1.494 T | -13,455.28% | 🇺🇸 USA |
 | ₹394.99 B | -3,629.10% | 🇺🇸 USA |
 | ₹952.38 B | -8,609.19% | 🇺🇸 USA |
 | -₹24.17 Billion | 115.93% | 🇮🇱 Israel |
 | ₹1.817 T | -16,338.13% | 🇺🇸 USA |